|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 255/51 | |
| A61K 31/167 | |||
| A61P 15/16 | |||
| C07C 255/60 |
| (11) | Number of the document | 3147278 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16194602.5 |
| Date of filing the European patent application | 2007-07-12 | |
| (97) | Date of publication of the European application | 2017-03-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 830158 P | 2006-07-12 | US | |
| 839665 P | 2006-08-24 | US | |
| 907748 P | 2007-04-16 | US |
| (72) |
DALTON, James T., US
MILLER, Duane D., US
|
| (73) |
University of Tennessee Research Foundation,
211 Conference Center Building 600 Henley Street, Knoxville, TN 37996,
US
|
| (54) | COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS |
| COMPOUND FOR TREATING BREAST CANCER AND PROGESTIN-DEPENDENT CONDITIONS |